1
Thomas J Ambrosio, Alan J Bilanin, Andrew E Kaufman, David J Kenyon, Srinivas Manthena, Tsong Toh Yang: Inhaler for powdered medications having spiral deagglomeration chamber. Schering Corporation, Robert A Franks, John J Maitner, Eric S Dicker, November 18, 1997: US05687710 (137 worldwide citation)

A powder dispenser includes a powder housing for holding a supply of powdered material to be dispensed, the powder housing including an inhalation conduit provided displaced relation to the powdered material supply; a metering plate including a metered dose hole for holding a metered amount of the p ...


2
James A Bristol, Chester Puchalski: Imidazo[1,2-A]pyridines and use. Schering Corporation, Gerald S Rosen, Bruce M Eisen, Anita W Magatti, May 22, 1984: US04450164 (116 worldwide citation)

This invention relates to imidazo[1,2-a]pyridine derivatives which are useful in the treatment of peptic ulcer diseases.


3
Frank Lee, Takashi Yokota, Ken ichi Arai, Timothy Mosmann, Donna Rennick: Mammalian interleukin-4. Schering Corporation, Stephen C Macevicz, May 21, 1991: US05017691 (110 worldwide citation)

Mammalian proteins and muteins thereof, designated interleukin-4s (IL-4s), are provided which exhibit both B cell growth factor activity and T cell growth factor activity. Compounds of the invention include native human and murine IL-4s, muteins thereof, and nucleic acids which are effectively homol ...


4

5
Charles R Ashley, Charles M Huck, Henry R Sochon, Ken Wilkinson: Inhaler for powdered medications with gear-teeth counter assembly. Schering Corporation, Eric S Dicker, Robert A Franks, April 21, 1998: US05740792 (100 worldwide citation)

A powder dispenser includes a powder housing for holding a supply of powdered material to be dispensed, the powder housing including an inhalation conduit provided displaced relation to the powdered material supply; a metering plate including a metered dose hole for holding a metered amount of the p ...


6
Kenneth G Draper: Antiviral oligomers. Schering Corporation, Norman C Dulak, James R Nelson, April 2, 1991: US05004810 (100 worldwide citation)

Oligomers that are complementary in base sequence to the initiation region on mRNA coding for herpes simplex virus transactivating proteins inhibit the replication of the virus.


7
John J Piwinski, Ashit K Ganguly, Michael J Green, Frank J Villani, Jesse Wong: Benzo[5,6]cycloheptapyridine compounds, compositions and method of treating allergies. Schering Corporation, James R Nelson, February 18, 1992: US05089496 (96 worldwide citation)

Derivatives of benzo[5,6]cyclohepta pyridine, and pharmaceutically acceptable salts and solvates thereof are disclosed, which possess anti-allergic and anti-inflammatory activity. Methods for preparing and using the compounds are also described.


8
Paul Glue, David L Cutler, Melton B Affrime: Polyethylene glycol modified interferon therapy. Schering Corporation, Jaye P McLaughlin, June 1, 1999: US05908621 (91 worldwide citation)

A method comprising administering a PEG.sub.12000 -IFN alpha conjugate to an individual afflicted with a viral infection susceptible of treatment with interferon alpha, preferably chronic hepatitis C, is disclosed.


9
Rudolph O Neri, John G Topliss: Methods for the treatment of hirsutism. Schering Corporation, Raymond A McDonald, Bruce M Eisen, February 13, 1979: US04139638 (90 worldwide citation)

This application relates to certain 4'-substituted and to 3', 4'-disubstituted anilides, to methods for their preparation and to methods for their use as antiandrogens. These substituted anilides are useful in the treatment of androgen dependent disease states, such as benign prostatic hypertrophy, ...


10
Rumin Zhang, Philip W Mui, Patricia C Weber: Synthetic inhibitors of hepatitis C virus NS3 protease. Schering Corporation, Jaye P McLaughlin, November 23, 1999: US05990276 (89 worldwide citation)

An inhibitor of the HCV NS3 protease. The inhibitor is a subsequence of a substrate of the NS3 protease or a subsequence of the NS4A cofactor. Another inhibitor of the present invention contains a subsequence of a substrate linked to a subsequences of the NS4A cofactor. In another embodiment the inh ...